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Abstract
Monitoring outcomes of health care providers, such as patient deaths, hospitalizations
and hospital readmissions, helps in assessing the quality of health care. We consider a large
database on patients being treated at dialysis facilities in the United States, and the problem
of identifying facilities with outcomes that are better than or worse than expected. Analy-
ses of such data have been commonly based on random or fixed facility effects, which have
shortcomings that can lead to unfair assessments. A primary issue is that they do not appro-
priately account for variation between providers that is outside the providers’ control due,
for example, to unobserved patient characteristics that vary between providers. In this ar-
ticle, we propose a smoothed empirical null approach that accounts for the total variation
and adapts to different provider sizes. The linear model provides an illustration that extends
easily to other nonlinear models for survival or binary outcomes, for example. The empirical
null method is generalized to allow for some variation being due to quality of care. These
methods are examined with numerical simulations and applied to the monitoring of survival
in the dialysis facility data.
Keywords: Health care provider profiling; Empirical null; Fixed effects; Random effects;
Non-linear models; Standardized mortality ratio.
1 Introduction
In many instances, the quality of medical care differs considerably across providers. Large health
care databases provide patient-level data that can be analyzed and summarized into provider-level
∗To whom correspondence should be addressed.
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measures in order to quantify and monitor such differences. Many important types of outcomes
are monitored including patient mortality, hospitalization and hospital readmission. Patient mor-
tality, after adjusting for relevant patient characteristics, is an outcome of substantial importance
(Jarman and others , 2010). Similarly, the rate of hospital readmissions following a hospital dis-
charge is important in monitoring hospitals and also other providers such as nursing homes and
dialysis facilities since it can be indicative of the degree of coordination of post-discharge care
(He and others , 2013; Wish, 2014). Provider profiling based on clinical outcomes can help pa-
tients make decisions in choosing health care providers, and also can aid overseers and payers in
identifying providers whose outcomes are worse or better than a normative standard, by signaling
the need for further review or to target quality improvement programs. The statistical analysis
along with further review may lead to financial consequences and even suspension for providers
with poor outcomes. Such evaluations require appropriate statistical methods that account for dif-
ferences in patient characteristics and suitably adapt to provider size to ensure no specific groups
of small or large providers are unfairly penalized in the assessment.
This paper is concerned with a large database assembled by the University of Michigan’s Kidney
Epidemiology and Cost Center and associated with its contacts with the Centers for Medicare &
Medicaid Services (CMS). A similar database is available from the United States Renal Data
Systems (USRDS), in the form of standard analysis files, for use in suitable research projects.
The data consist of longitudinal information on over half a million dialysis patients with end-
stage renal disease (ESRD) and associated with over 6,000 dialysis facilities in the United States.
These data are compiled from various sources within the CROWNWeb data system from the
CMS as well as supplementary data from the Social Security master death file. The CROWNWeb
data include demographic and administrative data on patients and dialysis facilities along with
ongoing reporting on treatment, the Medicare claims database which can be used to determine
hospitalizations, comorbidities, and other events, as well as the data on kidney transplants in the
United States. One important use of these data is to monitor dialysis facilities with respect to
various quality measures including mortality, hospitalization, and readmission. In this paper, we
consider the evaluation of mortality over a four-year period, accomplished through the calculation
of a standardized mortality ratio (SMR) for each dialysis facility. The SMR is a risk adjusted
measure which compares the observed number of deaths in a facility with the number of deaths
that would be expected if the mortality rate for the center, taking account of observed patient
characteristics, were the same as for a national norm (UM-KECC, 2018). The measure is typically
adjusted for many covariates including demographic characteristics, comorbidities at baseline, and
sometimes comorbidities identified over time. Adjusting for covariates after admission of the
patient to the facility must be done with care since such comorbidities may reflect treatment
choices.
Regression models for patient-level outcomes are typically used to adjust for observed pa-
tient characteristics. Methods are often based on hierarchical random effects models, in which
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the provider-specific effects are modeled as independent and identically distributed random vari-
ables. A typical analysis of these models is based on the empirical Bayes posterior distribution
of the provider effect where an individual provider effect is estimated by the posterior mean.
We refer to this as the random-effects (RE) approach. As is well known, this analysis yields
shrinkage estimates, i.e. the estimated provider effects are shrunk towards the overall average
(Jones and Spiegelhalter, 2011). Many authors have advocated this approach; see, for exam-
ple, Normand and others (1997); Normand and Shahian (2007); Jones and Spiegelhalter (2011);
Ohlssen and others (2007). An alternative approach, treating the provider effects as fixed, obtains
the maximum likelihood estimates of the provider effects. We refer to this as the fixed-effects ap-
proach (FE). In both approaches, it is common to use the estimate and its frequency or posterior
distribution to assess the sharp null hypothesis that a provider effect is identical to a national
norm. Much of the between-provider variation is typically outside the providers’ control due to
inadequate risk adjustment for unobserved or observed covariates associated with the outcome that
vary substantially between providers. Jones and Spiegelhalter (2011) and Kalbfleisch and others
(2018) stressed that all sources of variation should be taken into account in profiling.
In this paper, we propose empirical null methods that take into account the total variation as
a robustly modeled function of provider size. The empirical null was introduced in Efron (2004)
and Efron (2010) to account for overdispersion of Z-scores, and Efron (2007) described methods
to estimate a single empirical null distribution with an emphasis on controlling false discovery
rates. However, these approaches that estimate and refer to a single sampling distribution do
not apply immediately when providers vary markedly in size. In Kalbfleisch and Wolfe (2013)
and He and others (2013), this shortcoming was partially addressed through stratification. In this
article, we define an empirical null for each provider by smoothing the reference empirical null
distributions. Our proposal provides a unified framework for provider profiling that encompasses
various types of outcomes. We also generalize this approach to situation where a provider should
be held accountable for an externally specified proportion of the total variation that is due to the
quality of care.
In Section 2, we consider issues associated with profiling in the linear model where calculations
are more easily done and there is immediate comparison with familiar tests. These methods would
apply directly to a quality measure that is based on normally distributed variables. In Section 3,
we propose the empirical null methods with straightforward generalizations to other more complex
models as well. In Section 4, we illustrate the empirical null methods through simulation studies
and analysis of the ESRD dialysis facility data with respect to monitoring standardized mortality
ratios. Section 5 includes some discussion and extensions.
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2 Standard profiling methods based on the linear model
Let i = 1, · · · , N index providers and j = 1, · · · , ni index patients within the ith provider. We
consider an underlying linear regression model
Y ∗ij = µ+ αi + β
TXij + ǫij , (1)
where Y ∗ij represents the continuous outcome of interest with large values corresponding to poor
outcomes, µ is the grand mean, αi is the provider effect, Xij and β are vectors of patient charac-
teristics and regression coefficients, respectively. Our primary goal is to identify providers whose
outcomes are worse than expected.
In many instances, we assume that the αi’s are random and, conditional on Xij,
αi
iid∼ N(0, σ2α), independent of ǫij iid∼ N(0, σ2w). (2)
The parameters µ, σα, σw, and β appear in the probability laws for all observations, and thus
are estimated using all patient-level data. In what follows, we assume that the total numbers of
providers, N , and patients,
∑
i ni, are large, e.g. more than 500,000 patient records and over 6,000
dialysis facilities in our application, so that µ, σα, σw and β can be precisely estimated. Thus, we
proceed without considering the variation associated with their estimates and replace Y ∗ij ’s with
the risk adjusted responses, Yij = Y
∗
ij − βˆTXij , where βˆ, based on fixed effects for the αi’s, is
consistent for β. Ignoring variability in the estimation of these structural parameters is justified
in large healthcare databases. In much smaller applications, one should take into account the
associated variability by considering exact sampling distributions, adjustment of empirical Bayes
estimates or fully Bayesian methods (Jones and Spiegelhalter, 2011).
2.1 Fixed-effects, random-effects analysis, and fixed-effects with ran-
dom intercept
In a fixed-effects (FE) analysis, we consider the provider effect αi in (1) is a constant with a
constraint, usually
∑N
i=1 niαi = 0, for identifiability. The maximum likelihood estimator of αi is
αˆFEi = Y¯i − Y¯ , where Y¯i =
∑ni
j=1 Yij/ni and Y¯ =
∑N
i=1(niY¯i)/
∑N
i=1 ni. As noted above, Y¯ is an
accurate estimate of µ as is σˆw of σw. The FE Z-score for testing the sharp null of αi = 0 is
ZFE,i =
αˆFEi
σˆw/
√
ni
≈
√
ni(Y¯i − µ)
σw
, (3)
which has a N(0, 1) distribution under the null αi = 0. This can be used as the reference distribu-
tion to flag unusual providers. Then, one approach might be to flag the ith provider if ZFE,i > zρ,
where zρ is the upper ρth quantile of the standard normal distribution and ρ is the nominal
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significance level of the related one-sided test. We use ρ = 0.05 throughout this article.
The usual random-effects (RE) analysis of (1) is based on the assumption (2) that αi
iid∼
N(0, σ2α), i = 1, · · · , N , and that the provider effects αi are independent of patient character-
istics Xij, j = 1, · · · , ni. The latter is an important assumption in RE analysis that is rarely met
or noted. The confounding between αi and Xij can lead to substantially biased estimates of β
and can alter the estimates of αi (Kalbfleisch and Wolfe, 2013). One way to address such bias is
to utilize the fixed-effects estimate of β, i.e. βˆ, to provide an offset. As described earlier, we can
obtain the risk adjusted response, Yij, and then estimate σα, σw, µ and αi’s assuming the model
Yij = µ+ αi + ǫij .
An empirical Bayes approach gives the approximate posterior distribution of αi,
αi|{Yij} ∼ N
(
Ri(Y¯i − µ), Riσ2w/ni
)
, (4)
where Ri = σ
2
α/(σ
2
α + σ
2
w/ni). This approach yields an estimate αˆ
RE
i = Rˆi(Y¯i − Y¯ ) that is shrunk
toward zero by Rˆi. These RE estimates are conditionally biased; if the ith provider has true effect
αi, E(αˆ
RE
i |αi) ≈ Riαi. The corresponding RE Z-score for a test of αi = 0 from (4) is
ZRE,i =
Rˆi(Y¯i − Y¯ )√
Rˆiσˆ2w/ni
=
√
RˆiZFE,i ≈
√
Ri(Y¯i − µ)
σw/
√
ni
, (5)
which has a posterior reference distribution N(0, 1). Thus, analogous to the flagging rule in the FE
analysis, one flags a provider if ZRE,i > zρ. Note that this reference N(0, 1) is based on the posterior
distribution (4); the sampling distribution for ZRE,i given αi = 0 is approximately N(0, Ri) rather
than N(0, 1).
The FERE approach is based on FE estimates but accounts for the total (between and within)
variation. The corresponding Z-score is
ZFERE,i =
αˆFEi√
σˆ2α + σˆ
2
w/ni
≈ Y¯i − µ√
σ2α + σ
2
w/ni
. (6)
Analogous to FE and RE methods, one flags the ith provider if ZFERE,i > zρ. This is not a test
of the sharp null hypothesis αi = 0, but rather assesses whether Y¯i could reasonably have arisen
from the model (1).
2.2 Some comments on FE, RE and FERE
FE and RE methods are often used in profiling medical providers and are most appropriate when all
of the variation in provider effects is due to the quality of care. Both methods make reference to a
sharp null hypothesis, H0i : αi = 0. The RE approach is often thought to account for the variation
between providers. The RE approach has been promoted largely on the basis of the well-known
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result that, compared to FE, it improves the overall precision of estimating the provider effects by
“borrowing information” from other providers (Jones and Spiegelhalter, 2011; Efron and Morris,
1973; Louis, 1991; Krumholz and others , 2011). Thus, the mean squared error (MSE) of the
estimated provider effect is reduced by shrinkage, i.e. E
(
αˆREi − αi
)2 ≤ E (αˆFEi − αi)2. This result
is important in some contexts, but not in profiling. Consider, for example, the conditional MSE,
MSEmet(αi) = E
[
(αˆmeti − αi)2
∣∣∣∣αi
]
for met=FE, RE, plotted in Fig. 1, where σα = 1, σw = 5 and
ni = 100. Reduction in the overall MSE by RE is achieved by an average of substantial losses
for extreme values of αi and modest gains for more frequent values of αi closer to 0. This is an
example of an overall average missing important features. For profiling, it is the extreme values
that are of primary interest. For this reason among others, when the between-provider variation
is entirely due to the quality of care, the FE estimates are preferred for profiling purposes.
Although the FE approach produces unbiased estimates of the provider effects, the FE Z-scores
are substantially overdispersed compared to the standard normal reference distribution used in
testing αi = 0 (Efron, 2004; Spiegelhalter and others , 2012). The marginal variance of the FE
Z-score assuming randomness in the αi’s is
V ar(ZFE,i) ≈ σ
2
α + σ
2
w/ni
σ2w/ni
= 1 + ni
σ2α
σ2w
, (7)
which shows the variability in FE Z-scores, especially among large providers, is much larger than
the reference N(0, 1) distribution. The FE approach does not take into account such unexplained
variation and only assesses the sharp null hypothesis of a provider effect. A large sample size
can translate into more accurate estimation of the provider effect, and any deviation in αi from 0
will eventually be detected by FE as ni → ∞. As a result, the FE approach disproportionately
flags large providers even when their provider effects are small and not clinically meaningful.
Similarly, the marginal variance of ZRE,i increases linearly with ni, and the same problem persists.
With a large provider size ni, FE and RE are nearly identical and neither takes into account the
unexplained variation between providers.
Often, much of the variation in the αi’s is outside the providers’ control and cannot be attributed
to the quality of care. This can arise, for example, when there are unmeasured patient-level
covariates, such as socio-economic status, genetic differences and comorbidities, that are predictive
of the outcomes but vary substantially between providers. When most of the variation between
providers is outside of the providers’ control, the FERE approach is preferred and its advantages
have been discussed in the literature before, e.g. in the context of funnel plots which illustrate
how increasing provider size affects variation in the FE estimates (Jones and Spiegelhalter, 2011).
Providers that give rise to a large value of ZFERE,i have extreme values with reference to the
population of all providers, and include all sources of variation.
However, the usual FERE approach is not robust. When there exists a substantial proportion
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of providers with extreme outcomes, the between-provider variance σ2α is overestimated, which
compromises the ability of the FERE approach to identify extreme providers. Although it is
possible to develop robust estimates of σ2α (see, e.g., Koller 2016) to improve the FERE method,
generalizing them to non-linear models would be difficult.
3 Profiling based on the empirical null
The empirical null was introduced in Efron (2004) and Efron (2010) in the context of multiple
testing and controlling false discovery rates. The empirical null (EN) methods in this section
are designed to address overdispersion for fair assessments of all providers in a robust fashion to
outliers. These methods estimate the total variation in the FE Z-scores, ZFE,i, i = 1, . . . , N , to
assess extreme values in the empirical null distributions.
3.1 Linear model and the stratified EN approach
For the large majority of providers under consideration, suppose that the model (1) holds, with
αi
iid∼ N(0, σ2α). For now, we assume all providers have an equal number of patients, i.e. ni = n
for i = 1, · · · , N . The empirical null distribution is defined as the normal distribution with mean,
µˆM , and variance, σˆ
2
M , which are estimated robustly from the FE Z-scores ZFE,i, i = 1, . . . , N
so as to reduce or eliminate the impact of a relativelly small number of outlying providers. This
distribution is used in place of the reference N(0, 1) so that, for example, the ith provider is flagged
as “worse than expected” if ZFE,i > µˆM + zρσˆM .
To obtain robust estimates µˆM and σˆ
2
M , we adapt the “MLE fitting” method (Efron, 2007). This
is based on a mixture model in which a proportion pM of providers have Z-scores arising from the
empirical null distribution, N(µM , σ
2
M), whereas the remainder, including any outliers, come from
another non-null distribution. The target quantities µM and σ
2
M are estimated by maximizing the
mixture likelihood so that the estimates are robust to outliers. More specifically, we assume that
the non-null distribution has support outside an interval [A,B] ≡ [µ(0)M −ζ0·σ(0)M , µ(0)M +ζ0·σ(0)M ], where
(µ
(0)
M , σ
(0)
M ) are reasonable initial estimates and ζ0 > 0 is a specified constant (e.g. 1.2, 1.64, 1.96, or
2). Let I0 = {i : ZFE,i ∈ [A,B]}, N0 = |I0|, N1 = N−N0, φµ,σ(z) = 1√
2πσ2
exp
{
−1
2
(
z − µ
σ
)2}
,
and Q(µ, σ) = Φ
(
B − µ
σ
)
− Φ
(
A− µ
σ
)
, where Φ(·) is the cumulative distribution function of
N(0, 1), and θ = pMQ(µ, σ). Then the likelihood based on the observed Z-scores is
L(µ, σ, p) = θN0 [1− θ]N1
∏
i∈I0
φµ,σ(ZFE,i)
Q(µ, σ)
. (8)
To obtain the MLE, (µˆM , σˆM , pˆM) = argmax(µ,σ,p)L(µ, σ, p), we proceed by computing the profile
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likelihood of pM , which avoids solutions with pˆM > 1. Thus we define a grid of K values for p (e.g.
[0.5, 1] by increment of 0.001), denoted as {p(1), p(2), · · · , p(K)}. For each k = 1, 2, · · · , K, com-
pute ℓ(k) = maxµ,σ L(µ, σ, p
(k)) and the corresponding maximizer (µˆ(k), σˆ(k)). This maximization
step is over a 2-dimensional parameter and is very fast using existing optimization methods (e.g.
Nelder and Mead 1965). Finally, find k˜ = argmaxkℓ
(k), and then (µˆM , σˆM , pˆM) = (µˆ
(k˜), σˆ(k˜), p(k˜)).
An important strength of the MLE fitting approach is that the likelihood (8) is only parametric
within the interval [A,B], and is free from specifications of the distribution of outliers, all of
which only occur outside the interval. A robust M-estimation technique can be used to obtain
the preliminary estimates (Huber, 1964, 1973; Andrews and others , 1972). We use the bi-weight
function, which is the default in SAS® ROBUSTREG procedure (Chen, 2002). A stratified EN
approach was previously implemented using the robust M-estimation, in Kalbfleisch and Wolfe
(2013) and He and others (2013) for time-invariant profiling, and Estes and others (2018) for time-
dynamic profiling. The MLE fitting outlined above is preferable to the robust M-estimation, since
the latter can overestimate the variance with many outliers present. We have also found that
moderate values of ζ0 such as Φ
−1(0.9) = 1.28 or Φ−1(0.95) = 1.64 help avoid including outliers
while allowing good estimation of µM and σM .
Next we consider a more realistic setting where the sample size ni varies across providers.
Since the total variability of FE Z-scores depends on ni, we first stratify providers into a few
groups based on their sample sizes, as in Kalbfleisch and Wolfe (2013) and He and others (2013).
For example, we may stratify the providers into three groups based on the tertiles of sample sizes
{ni}. Within group g, we obtain the estimates µˆM,g and σˆM,g, and an empirical null distribution
N(µˆM,g, σˆ
2
M,g), g = 1, 2, 3. Each health care provider is compared to the empirical null correspond-
ing to its group.
As an illustration, consider the mortality data from the ESRD database introduced in Section
1, on patients treated at 6,363 dialysis facilities in the United States over four calendar years, from
2012 to 2015. More data descriptions can be found in Section 4.3. Facilities are stratified into three
groups, small, medium and large facilities, using facility size tertiles. The failure rates are modeled
using a Cox model with covariates measuring demographic variables and comorbidities at baseline.
The SMR (see Section 1) is obtained for each facility and each is converted to a one-sided Z-score
based on a test of the sharp null hypothesis. These are used in an extension of the EN methods
to non-linear models as discussed in detail in Section 3.3. The estimated means of one-sided Z-
scores are −0.02, −0.07 and −0.13 for the small, medium and large groups respectively, and the
corresponding variance estimates are 1.232, 1.402 and 1.612; see Fig. 2(a)-(c) for Z-score histograms
along with the empirical null distributions. It can be seen that the empirical null distributions
are more dispersed than the standard normal, and that the variation of Z-scores increases with
facility size. We use the upper 5% quantiles in the empirical null distributions as critical values,
and facilities with Z-scores larger than those in their corresponding groups are flagged as having
poor outcomes. Fig. 2(e)-(f) visualizes the stratum-specific critical values of Z-scores in the scatter
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plot (solid blue segments).
3.2 Smoothing empirical null distributions
The stratified empirical null approach has some limitations, as evident from Fig. 2(e)-(f). First,
the choice of three groups is arbitrary and a different number of strata will result in changes in
the list of flagged providers. A second related problem is the discontinuity of the critical region at
the stratum boundaries. Consequently, two providers near a boundary may have similar sizes and
Z-scores, yet one may be flagged and the other not, due only to the arbitrary choice of boundaries.
To overcome these issues, we model the mean and variance of the empirical null distributions as
smooth functions of provider size, and use robust techniques to lessen the impact of potential
outliers.
To estimate the regression of the variance on the provider size, we first obtain variance estimates
in each of G groups defined by quantiles of provider sample size. We then regress these variance
estimates on the median provider size in each group. Specifically, we proceed as follows. Within
the gth group, we use the local MLE fitting described in Section 3.1 to estimate the mean z˜g and
variance σ˜2g of Z-scores, and let m˜g represent the median size in this group, g = 1, · · · , G. Focusing
first on the variance estimates, we fit a regression model with variance estimates {σ˜2g} as dependent
and median sizes {m˜g} as independent variables. Based on our empirical studies and theoretical
derivations, a linear regression of the form γ0+γ1m˜g will typically suffice. An iteratively re-weighted
algorithm is used to estimate (γ0, γ1). We set the initial estimates as the ordinary least squares
estimates (γˆ
(0)
0 , γˆ
(0)
1 ), then update with (γˆ
(t+1)
0 , γˆ
(t+1)
1 ) = argmin(γ0,γ)
∑G
g=1 ω
(t)
g (σ˜2g−γ0−γm˜g)2 until
convergence, where the weights ω
(t)
g = Ng(γˆ
(t)
0 + γˆ
(t)
1 m˜g)
−2 and Ng is the number of providers in
the gth group. The final fitted variance values for each providers are denoted as σˆ2i , i = 1, · · · , N .
We include weights in the regression to reduce the leverage of the variance estimates with large
variability from large providers.
An important issue is the choice of the total number of groups G. A small G will not provide
sufficient information for estimating regression coefficients precisely in a linear model, whereas a
large G results in a very small number of providers in each group and consequently unstable within
group variance estimates. From our experience with the SMR example, we find it satisfactory to
choose G that there are 50 to 300 providers in each group. The estimated mean and variance
functions under different choices for G are fairly stable, as reported in the supplementary material
Section S2.
To estimate the mean Z-score as a function of provider size, we use a weighted smoothing tech-
nique such as smoothing spline, B-spline or LOESS on data {(z˜g, m˜g)}Gg=1. The weight associated
with the mean estimate z˜g in the gth group is inversely proportional to the variance estimate σˆ
2
g
from the iteratively re-weighted algorithm above. One can easily find existing implementations for
these methods, for example, smooth.spline() for smoothing spline in R. For the provider size that
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falls outside the range of {m˜g}Gg=1, one may extrapolate either with the estimated linear function
or with a plateau so that the mean function remains continuous and flat. The fitted Z-scores from
smoothing are denoted as Zˆi, i = 1, · · · , N . We propose this group-based smoothing instead of
direct smoothing based on the original Z-scores, because the MLE fitting within each group is
more robust against potential outliers.
Examination of the ith provider may proceed based on the individual empirical null distribution
N(Zˆi, σˆ
2
i ). Similar to other methods, the ith provider is flagged as worse than expected if ZFE,i >
Zˆi + zρσˆi, for a one-sided test with nominal level ρ. Smoothing provides a better approximation
to the total variance of Z-scores and avoids any unfairness associated with simple stratification.
When the normal linear model (1) holds for all providers, this approach gives an almost identical
result to the FERE approach. Fig. 2(e)-(f) show the critical line for flagging dialysis facilities with
poor outcomes in the SMR data using the smoothed empirical null (zρ = 1.64 for black dotted
lines).
3.3 Extensions to non-linear models
Many types of outcomes are monitored for quality of care, including patient hospitalizations, read-
missions, transfusions and death events in the ESRD dialysis facility data. A hospital readmission
measure within thirty days following a hospital discharge is based on a logistic model for binary
outcomes, and 30-day mortality rates are analyzed in a similar manner. Hospitalizations are ana-
lyzed using a model for recurrrent events. The empirical null approach can be readily extended to
non-linear models and provides a unifying framework for profiling providers.
We continue using the SMR example, which assesses patient death events within a health care
provider. For the ith provider, we denote the observed number of deaths by Oi. A two-stage
modeling procedure is used to obtain the expected number of deaths under the assumption that
patients of this provider have death events at the national average rate (UM-KECC, 2018). The
following is the approach currently adopted by CMS in Dialysis Facility Compare.
In the first stage model, the hazard function of the jth patient in the ith provider is assumed
to be λij(t) = λ0i(t) exp{XTijβ}, where λ0i is a provider-specific baseline hazard, and β represents
the regression coefficients associated with the observed patient-level characteristics Xij such as
age, gender, race, BMI and a selected set of comorbidities. This stratified Cox model is fitted to
the national data in order to estimate β, denoted as βˆ. Stratification by providers is important to
accurately estimate the within provider effects of covariates, β.
In the second stage, the “population-average” cumulative baseline hazard Λ0(t) =
∫ t
0
λ0(u)du
is estimated through an unstratified Cox model with an offset, XTij βˆ, obtained from the first
stage. Conditional on patient characteristics Xij and at-risk process Yij(t), the expected number
of events for the jth patient in the ith provider is calculated as Eij =
∫ τ
0
Yij(t) exp{βˆTXij}dΛˆ0(t),
where τ is the maximum follow-up time. For the ith provider, the expected number of events is
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Ei =
∑ni
j=1Eij and the corresponding SMR is estimated by ŜMRi = Oi/Ei. If ŜMRi > 1(< 1),
the ith provider experiences more (fewer) deaths than expected under the national norm given the
observed characteristics of patients. Note that Eij is a sum of conditional expectations and is in
fact the compensator in the martingale corresponding to the counting process for the individual.
A test of the sharp null hypothesis H0i : SMRi = 1, where SMRi is the underlying SMR for
the ith provider, can be obtained using a Poisson approximation whereby the number of events
Oi is assumed to follow a Poisson distribution with mean Ei. In this case, the one-sided mid
p-value is pi = P (X = Oi)/2 + P (X > Oi), where X ∼ Poisson(Ei). These can be converted to
Z-scores using ZFE,i = Φ
−1(1 − pi). By this convention, large values of ZFE,i are associated with
poor outcomes. Mid p-values are used to avoid difficulties in converting p-values to Z-scores. The
Poisson-based p-values in this example are preferable rather than a normal approximation with
Z-scores
Oi − Ei√
Ei
, since they are more accurate when the provider size is small.
These FE Z-scores are consequently used to construct empirical null distributions for profiling,
as introduced in Sections 3.1 and 3.2. A similar approach applies directly to other standardized
measures based on other regression models, such as hierarchical logistic regression for hospital
readmission. Instead of converting p-values, FE Z-scores could also be based on Wald statistics
from fixed-effects estimates of provider effects and a test of the sharp null hypothesis. FE and RE
methods analogous to those in the linear model are also sometimes used. RE methods tend to be
complicated and subject to the same concerns as described in Section 2.2 for the linear model, and
they behave similarly to FE methods in large providers and result in unreasonably higher flagging
rates for large providers.
3.4 Allowing some of the variation to be due to quality of care
Similar to FERE, the empirical null approach presented above takes account of the total variation
in the Z-scores. This is appropriate when most or all of the between-provider variation is due
to incomplete risk adjustment, as opposed to the quality of care. Kalbfleisch and others (2018)
suggests introducing a value, λ, that represents the proportion of the between-provider variance
that is due to incomplete risk adjustment, and holding providers accountable for a proportion of
1 − λ of the between-provider variation. Note that λ cannot be estimated on the data and must
be specified based perhaps on expert opinion.
In the linear model (1), we can write αi = αi1+αi2, where αi1 ∼ N(0, (1−λ)σ2α) represents the
portion of the effect due to the quality of care whereas the independent effect, αi2 ∼ N(0, λσ2α),
is variation that is outside the provider’s control. In this case, it is natural to base profiling on
an assessment of the hypothesis Hλ : αi1 = 0. Under this hypothesis, the null distribution for
ZFE is N (0, (λσ
2
α + σ
2
w/ni)/(σ
2
w/ni)). This is a natural generalization that connects the FE and
FERE approaches discussed in Section 2, which correspond respectively to λ = 0 and λ = 1.
Furthermore, for a general 0 ≤ λ ≤ 1, the null distribution for ZFE,i can also be written as
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√
1− λ N(0, 1) + √λ N(0, 1/(1 − ri)). Here, ri = σ2α/(σ2α + σ2w/ni), the shrinkage factor defined
earlier, is also referred to as the inter-unit reliability (IUR).
Analogous to the relaxation in the linear model above, we can extend the idea of decomposing
the between-provider variance to the empirical null in non-linear models. Suppose we have obtained
the empirical null distribution for a provider, N(Zˆi, σˆ
2
i ). The IUR, in general, represents the
proportion in the total variance that the between-provider variance takes, and can be computed
in non-linear models (He and others , 2019). Then, for the ith provider with an IUR equal to ri,
the variance to be allowed is
σˆ2λ,i = σˆ
2
i − ri · σˆ2i (1− λ) = [1− ri(1− λ)]σˆ2i . (9)
Additionally, if the FE Z-scores are computed as Wald statistics or asymptotically equivalent
statistics by assuming fixed provider effects, the variance in the reference distribution σˆ2i can be
approximated by 1/(1−ri) when all between-provider variation is due to incomplete risk adjustment
(λ = 1), and σˆ2λ,i in (9) can also be written as σˆ
2
λ,i = 1− λ + λσˆ2i . The new reference distribution
allowing a proportion λ of the between-provider variance is N(Zˆi, σˆ
2
λ,i). Note that the incorporation
of λ simply changes the critical value of the test based on the empirical null.
More generally, we might elicit a prior distribution fλ(λ) for λ that reflects experts’ uncertainty
about its value. In this case, we might gauge a provider’s performance by comparing its FE Z-score
to the marginal empirical null distribution. Since the distribution of the data does not depend on
λ, the posterior distribution is the same as the prior. The marginal empirical null distribution has
density
∫ 1
0
fEN(z|λ)fλ(λ)dλ, where fEN(z|λ) is the density of N(Zˆi, σˆ2λ,i). This distribution can be
approximated with Monte Carlo methods that draw random samples from fλ(λ) and then fEN(z|λ).
Given (Zˆi, σˆ
2
i ), the mean of the marginal distribution is simply Zˆi and the variance is obtained by
substituting λ with its prior mean in (9). Depending on the prior, the marginal can have heavier
tails than a normal distribution. Detailed discussion is presented in the Supplementary Material
Section S3.
4 Numerical studies
4.1 Simulation in linear regression models
We first restrict all providers to have the same sample size, and compare the probability that
providers give rise to a signal under different approaches. We assume the true model (1), with
µ = 0, β = 0, ǫij ∼ N(0, 16), αi ∼ N(0, 1) for i ≥ 2 and α1 fixed at a value varying from 0 to 3.5.
We simulate N = 200 providers of size ni = n for all i, where n = 10, 25, 50, 100. The simulation
is repeated 1000 times. For one-sided tests, providers whose Z-scores exceed the corresponding
critical value Φ−1(0.95) = 1.64 are flagged as worse than expected.
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Fig. 3 shows the estimated probabilities of signaling provider 1 for FE, RE, FERE and EN
approaches. The FE approach flags provider 1 with the highest probabilities in all cases. As
expected, the difference between FE and RE diminishes for a large sample size n. Without out-
lying providers, FERE and EN result in almost identical probabilities of signaling, reflecting their
asymptotic equivalence in this setup. For a large sample size, e.g. n = 100, standard FE and RE
methods signal provider 1 with moderate to high probability even with relatively small values of
α1, say α1 = 0.5 or 1. These values of α1 are well within the range of variation expected for αi
under the true model. On the other hand, FERE and EN allow for this variation and do not signal
with high probability until α1 > 2.0, that is until the effect is in the tail of the distribution of
provider effects (σα = 1). It should be noted that the exact probability of flagging can be easily
calculated and plotted for all methods except EN. We present the empirical probability in all cases
to facilitate fair comparison.
To illustrate the robustness of EN compared to FERE, we also simulate N = 3, 000 providers
with 5% outliers. Still, we assume model (1) for the majority of providers, with µ = 0, β = 0,
σw = 4, and σα = 1 except that α1 is fixed at a value varying from 0 to 3.5σα. Half of the
outliers have provider effect αi = 4σα and the other half αi = −4σα, well outside the center of the
true distribution for the majority of provider effects. Sample size ni is simulated from a uniform
distribution on integers {10, 11, · · · , 150} for all providers except provider 1. For provider 1, its
sample size n1 = 25, 50, 100, 125. The empirical null distribution is smoothed using the methods
in Section 3.2. The simulation is repeated 1000 times. Fig. 4 plots the proportion of times that
provider 1 is flagged in the presence of 5% outliers. In this setting, the EN method results in
almost identical performance compared to the case when the true variance parameters σα and σw
are known (black dashed line), and is more robust than FERE, which has lower flagging proportions
due to over-estimation of the between-provider variance, especially when n1 is large.
4.2 Simulation of the SMR
We consider a realistic situation where providers are of different sizes and simulate survival out-
comes that mimic the SMR example in Section 3.3. A similar study where providers are of the
same size is presented in the Supplementary Materials Section S1.
We generate N = 2000 providers whose sample sizes are simulated from a uniform distribution
on integers in [10, 200], and then fixed throughout. For the jth subject in the ith provider, the sur-
vival time Tij follows an exponential distribution with hazard λij = 0.1×exp{αi+Xij1β1+Xij2β2},
where β1 = 1 and β2 = −1, αi iid∼ N(0, 0.22) are the provider effects, and the covariates, Xij1 and
Xij2, are independent N(0, 1) variables. The censoring time Cij
iid∼ Unif(10, 30), which generates
approximately 27% censoring. We fit a Cox proportional hazards model with facilities as strata
and obtain regression coefficient estimates for the covariates. The raw p-values and corresponding
Z-scores are computed as described in Section 3.3. We implemented the smoothed empirical null
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approach from Section 3.2 with different numbers of groups G = 5, 20, 40, 60. Linear regression
models are fitted to the group-wise variance estimates of Z-scores, and weighted smoothing splines
to the group-wise mean estimates. We repeat the simulation 500 times.
Fig. 5(a)-(b) show the estimated mean and variance functions of Z-scores in one replication
when the number of groups G = 20. Results with different G show no sensitivity to the selection
of G in the range 5 to 60 (Section S2 in the Supplementary Materials). Our proposed method
captures the main features of the mean and variance functions while being smooth enough to
provide consistent flagging rules within the considered range of provider size.
If one assumes that a proportion λ of the between-provider variance is due to incomplete risk
adjustment, then the methods of Section 3.4 can be used. Following the same simulation setup
with survival outcomes above, we consider λ = 0, 0.5, 0.75, 1 and modify the allowed variance σˆ2λ,i
in the reference distribution accordingly. Fig. 5(c) shows box plots of the proportion of times
that providers are flagged in 500 replications, stratified into three groups. The FE approach,
corresponding to λ = 0, flags a provider if its one-sided p-value is less than 0.05, which results in
over 25% of the large providers and about 15% of the small providers being signaled. In contrast,
the EN approach that allows all variation (λ = 1) has very stable flagging rates around 5% for all
three groups. The EN approach with the relaxed factor λ can be viewed as a hybrid of the FE
analysis and the EN allowing total variance, hence its flagging rates lie between the latter two.
When λ = 0.5, 0.75, the flagging rates increase somewhat with provider size, a feature inherited
from FE.
4.3 Mortality in U.S. dialysis facilities
The Standardized Mortality Ratio (SMR) is used as a measure of mortality to profile dialysis
facilities at CMS. More details on SMR can be found in Sections 1 and 3.3. Data were collected
from 2012 to 2015, involving over half a million dialysis patients. In this analysis, we include 6,363
dialysis facilities with expected number of deaths of 3.0 or more. The number of observed deaths
ranges from 0 to 581, the number of expected deaths from 3.0 to 308.6, and the facility sizes ranges
from 6.9 to 1569.8 patient-years. Facility size tertiles, defined by cut points at 156.9 and 302.8
patient-years, create three groups of small, medium and large facilities.
Fig. 2 shows the histograms of FE Z-scores by stratum, the distribution of facility size and
different flagging threshold lines for the stratified and the smoothed EN methods, and has been
discussed in Section 3. Switching from the stratified EN to the smoothed version changes the
flagging labels for some facilities. Nine facilities are flagged as “worse than expected” by the
stratified EN but not the smoothed EN, and 18 facilities are flagged by the smoothed EN but
not the other. A total of 367 facilities are flagged by both EN methods, and 5,968 facilities by
neither. The FE approach results in 768 facilities being flagged (12.1% of the total number), with
231 (10.9%), 241 (11.4%) and 296 (14.0%) in the small, medium and large groups, respectively
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(percentages are with respect to the number of facilities in each group). The FE approach flags
more large facilities than small ones, and the flagging rates exceed the target 5% by large margins
due at least in part to overdispersion. Using the smoothed EN, the flagging rates in the three
groups are brought down to a more equitable level, 141 (6.6%), 109 (5.1%) and 123 (5.8%). Due
to possible existence of outliers, the empirical null based flagging rates are slightly larger than the
target level.
5 Conclusions and Discussion
Besides the comments in Section 3.4, one may also choose a λ value that would result in a certain
proportion of providers being flagged, especially when there are constraints on resources made
available for the review process or quality improvement program. This could also be accomplished
by changing the nominal flagging rate ρ.
Generalization of RE and FERE methods to non-linear models, such as the logistic model
or the Cox proportional hazards model, is complicated. For example, methods developed for
assessing hospital readmission rates were based on an RE analysis of a hierarchical logistic model
(Horwitz and others , 2011), and entailed complicated bootstrap techniques to assess significance.
The EN method, however, generalizes immediately as described in Section 3.3, and is applied to a
more complicated logistic model for hospital readmissions of dialysis patients in (He and others ,
2013).
In the EN approach, we have assumed that there are a large number of providers to be profiled
and that the central part of the histogram of Z-scores is well described by a normal distribution.
These two assumptions are satisfied in many applications. When the number of facilities is much
smaller, it is important to take into account uncertainty in the estimation of the empirical null
distribution. Also, in some instances, it may be useful to use a transformation of the basic mea-
sure in order to achieve approximate normality of the empirical null. In other cases, there may
be situations where a non normal distribution that incorporates skewness, for example, is more
appropriate. These are areas where additional work is needed.
As noted earlier, an FE analysis to estimate β and then use of an offset is one approach
to correct for the confounding between covariates and provider effects in the RE method. An
alternative approach is to include both a within and a between regression coefficient in the model
Yij = µ+ αi + β
T
w(Xij − X¯i) + βTb X¯i + ǫij
as described in Neuhaus and Kalbfleisch (1998). A feature which sometimes arises is that the
between-provider regression coefficient, βb 6= βw, in which case the within coefficient does not
make a full adjustment for the covariates under consideration. This would arise, for example, if
even having adjusted for a variable like race, one found that there was still a difference between
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providers according to the racial mix that they treat. Such situations require careful consideration,
and a discussion of issues associated with this can be found in Kalbfleisch and others (2018).
Bayesian methods are computationally attractive and have often been used in profiling. These
impose distributional assumptions on the random provider effects, often with hyperparameters in
full Bayesian methods (Normand and others , 1997; Racz and Sedransk, 2010; Normand and Shahian,
2007). However, there still remains confusion as to nonunified criteria for identifying outly-
ing providers based on posterior distributions. For instance, Racz and Sedransk (2010) assessed
whether a pre-determined norm lies between the posterior percentiles, e.g. 2.5% and 97.5%, of a
provider effect in a hierarchical logistic regression model. Normand and others (1997) considered
the posterior probability of the excess expected mortality (the difference between the expected mor-
tality under a provider’s own regression coefficients and that averaged over the provider-specific
parameters) being larger than a benchmark, and the posterior probability of the adjusted mortality
of a reference patient greater than that for similar patients in all providers in the same sample.
Often, extremeness of the observed mortality have also been assessed based on the posterior pre-
dictive distrbution through replications (Normand and Shahian, 2007). Based on a hierarchical
logistic regression model, Bayesian intervals can be constructed for standardized readmission mea-
sures via bootstrapping from a normal approximation to the posterior distribution of provider
effects in an approach similar to the RE methods discussed in this paper. As with RE methods, it
is worthwhile to take measures with a Bayesian approach to ensure fair assessments of providers
of all sizes.
A causal inference framework provides a promising but challenging approach to profiling health
care providers. In general, the existence of unmeasured confounders poses difficulties in the in-
ference on providers’ performance. Spertus and others (2016) implemented augmented inverse
probability weighting (Robins and others , 1994) and targeted maximum likelihood estimation
(van der Laan and Rubin, 2006) under a causal inference framework for profiling, coupled with
elastic net for variable selection. Spertus and others (2016) discussed using instrumental variables
if one has strong reasons to assume the underlying causal mechanism. As is often the case, for
causal inference, cautions are needed in connection with many commonly made but non-verifiable
assumptions.
Software
The R code for implementing the empirical null with simulation examples in this paper has been
made available at https://github.com/luxia-bios/Empirical-Null.
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Supplementary Material
Supplementary material will be available online at http://biostatistics.oxfordjournals.org.
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Figure 1: Conditional and marginal MSEs of the FE and RE estimates of αi in the linear model
(1). Conditional MSEs are calculated conditional on the true value, αi. Here σα = 1, σw = 5 and
ni = 100. The marginal MSE of the FE estimate coincides with its conditional MSE.
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Figure 2: Histograms of FE Z-scores in dialysis mortality data (SMR), stratified by facility size
tertiles into (a) small, (b) medium, and (c) large facility groups. The smooth curves represent
the standard normal and the empirical null distributions. (d) Histogram of facility size in patient-
years. (e) Scatter plot of FE Z-scores versus facility size along with flagging thresholds based on
the stratified EN (solid blue lines) and the smoothed EN (dotted black lines). The two vertical
grey lines separate facilities into three groups by the tertiles of facility size. The red square in (e)
is magnified in (f).
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Figure 3: Estimated probability of signaling provider 1 as worse than expected under the linear
model (1), with all providers having sample size (a) n = 10, (b) n = 25, (c) n = 50, and (d)
n = 100. The x-axis represents the fixed value of α1.
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Figure 4: Estimated probability of signaling provider 1 as worse than expected under the linear
model (1), with 5% outliers, µ = 0, β = 0, σw = 4 and σα = 1. Provider sample sizes are drawn
from a discrete uniform distribution except for provider 1 with (a) n1 = 25, (b) n1 = 50, (c)
n1 = 100 and (d) n1 = 125. Outlier effects have equal probability of taking values of ±4. The
x-axis represents the fixed value of α1. Dashed black lines represent the estimated probability
when the true parameters σ2w and σ
2
α are known.
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Figure 5: (a) Estimated mean function and (b) estimated variance function, by the smoothed
empirical null, in one replication of the simulation with survival outcomes, with the number of
groups G = 20. Black dots represent group-wise robust mean and variance estimates of Z-scores.
(c) Boxplots of empirical probability of signal summarized over 500 replications, all providers
stratified into three groups by provider size. A proportion λ = 0, 0.5, 0.75, 1 of the between-
provider variance is assumed to be due to incomplete risk adjustment, and the rest due to the
quality of care. λ = 0 corresponds to the fixed-effects analysis.
24
